+8,077.9%
AMD vs CVS
+57.7%
+8,020.3%
-65.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | +14.7% | +6.2% | +8.6% | +12.8% |
| 7D | +6.5% | -2.6% | +9.1% | +7.1% |
| 30D | -15.3% | +4.0% | -19.3% | -16.8% |
| 3M | +9.7% | -6.3% | +16.0% | +11.1% |
| 6M | +13.2% | -0.4% | +13.6% | +11.6% |
| YTD | +140.6% | +15.6% | +125.0% | +124.1% |
| 1Y | +111.2% | +18.3% | +92.9% | +95.0% |
| 3Y | +334.4% | +47.3% | +287.2% | +255.3% |
| 5Y | +268.3% | +13.2% | +255.2% | +237.0% |
| 10Y | +8,077.9% | +57.2% | +8,020.8% | +6,211.1% |
| All | +8,077.9% | +57.7% | +8,020.3% | +6,211.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling